{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:15:44Z","timestamp":1777292144709,"version":"3.51.4"},"reference-count":169,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"DST-RFBR","award":["INT\/RUS\/RFBR\/P-256"],"award-info":[{"award-number":["INT\/RUS\/RFBR\/P-256"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1080\/14737140.2020.1807950","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:38:07Z","timestamp":1596886687000},"page":"797-811","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Osteolytic metastasis in breast cancer: effective prevention strategies"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2292-6635","authenticated-orcid":false,"given":"Chandi C","family":"Mandal","sequence":"first","affiliation":[{"name":"Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-4799-2"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000489184"},{"issue":"165","key":"e_1_3_5_6_1","article-title":"High cholesterol deteriorates bone health: new insights into molecular mechanisms","volume":"6","author":"Mandal CC.","year":"2015","unstructured":"Mandal CC. High cholesterol deteriorates bone health: new insights into molecular mechanisms. Front Endocrinol. 2015;6(165).","journal-title":"Front Endocrinol"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-012-9373-9"},{"issue":"2","key":"e_1_3_5_8_1","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget S","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1590"},{"issue":"1","key":"e_1_3_5_10_1","first-page":"3","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo F","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, et al. Bone metastases: an overview. Oncol Rev. 2017;11(1):3.","journal-title":"Oncol Rev"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00313"},{"issue":"10","key":"e_1_3_5_12_1","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"6","author":"Clines GA","year":"2008","unstructured":"Clines GA, Guise TA. Molecular mechanisms and treatment of bone metastasis. Expert Rev Mol Med. 2008;6(10).","journal-title":"Expert Rev Mol Med"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00852"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2016.02.008"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.2.206"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-015-9349-9"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-1909-x"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.04.005"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10186"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3618"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004563218759371"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-012-0105-4"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-013-9741-7"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/154405910608500703"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.167"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81558-5"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-011-0078-8"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/08977190412331279890"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2014.07.005"},{"key":"e_1_3_5_30_1","first-page":"1","article-title":"An update of bone morphogenetic proteins as biomarker and therapy for cancer","volume":"6","author":"Mandal CC","year":"2015","unstructured":"Mandal CC, Rahman MM. An update of bone morphogenetic proteins as biomarker and therapy for cancer. J Carcinogenesis Mutagenesis. 2015;6:1.","journal-title":"J Carcinogenesis Mutagenesis"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.668939"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.2929"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/boneres.2015.5"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9419-3"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0026"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1350705"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000059406.92165.31"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80258-5"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00622-5"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00552.2003"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.09.023"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2006.04.006"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1270"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.455733"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20100357"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511071200"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0139"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9820"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.5603\/NMR.2013.0037"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-014-1846-4"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.12.022"},{"issue":"1","key":"e_1_3_5_52_1","first-page":"019","article-title":"FOXF2 reprograms breast cancer cells into bone metastasis seeds","volume":"10","author":"Wang S","year":"2019","unstructured":"Wang S, Li GX, Tan CC, et al. FOXF2 reprograms breast cancer cells into bone metastasis seeds. Nat Commun. 2019;10(1):019\u201310379.","journal-title":"Nat Commun"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8 <1546::AID-CNCR4>3.0.CO;2-I"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-005-5399-8"},{"issue":"358","key":"e_1_3_5_55_1","article-title":"Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model","volume":"8","author":"Regan JN","year":"2017","unstructured":"Regan JN, Mikesell C, Reiken S, et al. Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model. Front Endocrinol (Lausanne). 2017;8(358).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.002"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.12.014"},{"issue":"2","key":"e_1_3_5_58_1","first-page":"14","article-title":"The calcineurin\/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells","volume":"6","author":"Quang CT","year":"2015","unstructured":"Quang CT, Leboucher S, Passaro D, et al. The calcineurin\/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells. Cell Death Dis. 2015;6(2):14.","journal-title":"Cell Death Dis"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb816"},{"key":"e_1_3_5_60_1","first-page":"1","article-title":"Docosahexaenoic acid (DHA) inhibits bone morphogenetic protein-2 (BMP-2) elevated osteoblast potential of metastatic breast cancer (MDA-MB-231) cells in mammary microcalcification","volume":"14","author":"Sharma T","year":"2019","unstructured":"Sharma T, Sharma A, Maheshwari R, et al. Docosahexaenoic acid (DHA) inhibits bone morphogenetic protein-2 (BMP-2) elevated osteoblast potential of metastatic breast cancer (MDA-MB-231) cells in mammary microcalcification. Nutr Cancer. 2019;14:1\u201311.","journal-title":"Nutr Cancer"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2017.1309548"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs198"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.2741\/3725"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1594-1"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26745"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138189"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002942"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1933"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b02283"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx114"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027090"},{"issue":"10","key":"e_1_3_5_73_1","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"10","author":"O\u2019Carrigan B","year":"2017","unstructured":"O\u2019Carrigan B, Wong MH, Willson ML, et al. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2017;10(10):CD003474.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2015.965333"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600886"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.01.009"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.116.186833"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0036-5"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.002"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.4172\/1948-5956.1000316"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606706200"},{"issue":"6","key":"e_1_3_5_82_1","first-page":"576","article-title":"Statin use and reduced cancer-related mortality","volume":"368","author":"Nielsen SF","year":"2013","unstructured":"Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med. 2013 Feb 7;368(6):576\u2013577.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.04.005"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30526"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.379"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16936-5"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2009.12.010"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.193714"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209435"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201901388R"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.10.063"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0227-7"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2703-y"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037366"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.208066"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao1193"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2018.10.027"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2010.2234"},{"issue":"10","key":"e_1_3_5_99_1","first-page":"13333","article-title":"Omega-3 fatty acids in pathological calcification and bone health","volume":"17","author":"Sharma T","year":"2020","unstructured":"Sharma T, Mandal CC. Omega-3 fatty acids in pathological calcification and bone health. J Food Biochem. 2020;17(10):13333.","journal-title":"J Food Biochem"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1460678"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2016.1115097"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2019.20.3.911"},{"issue":"8","key":"e_1_3_5_103_1","first-page":"806","article-title":"\u03b1-tocopheryl succinate affects malignant cell viability, proliferation, and differentiation","volume":"81","author":"Savitskaya MA","year":"2016","unstructured":"Savitskaya MA, Onischenko GE. \u03b1-tocopheryl succinate affects malignant cell viability, proliferation, and differentiation. Biochemistry. 2016;81(8):806\u2013818.","journal-title":"Biochemistry"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719283"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2018.25.1.23"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.05.051"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24010013"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2012"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.5.774"},{"issue":"4","key":"e_1_3_5_110_1","first-page":"957","article-title":"Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis","volume":"300","author":"Ohshiba T","year":"2003","unstructured":"Ohshiba T, Miyaura C, Ito AJB. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. Commun Br. 2003;300(4):957\u2013964.","journal-title":"Commun Br"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-09-0257"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0731"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.09.018"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3194"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2011.05648.x"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.03.025"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0566-5"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5593"},{"issue":"4","key":"e_1_3_5_119_1","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng AL","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895\u20132900.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155211416530"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1470-2"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10024-2726"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-018-1950-0"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.03.013"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1021\/np300663v"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1039\/c2ib20045g"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2018.09.021"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.09.026"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12405"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0885-7"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2017.06.043"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7352"},{"issue":"2","key":"e_1_3_5_133_1","first-page":"157","article-title":"A case of recurrent breast cancer with bone metastasis successfully treated with everolimus and exemestane therapy","volume":"44","author":"Kubo H","year":"2017","unstructured":"Kubo H, Kimura Y, Kawaoka T, et al. A case of recurrent breast cancer with bone metastasis successfully treated with everolimus and exemestane therapy. Gan To Kagaku Ryoho. 2017;44(2):157\u2013160.","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.37241"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1202-4"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.9331"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs216"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2960"},{"issue":"2","key":"e_1_3_5_139_1","first-page":"1808","article-title":"Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt\/\u03b2\u2011catenin pathway","volume":"20","author":"Xie B","year":"2019","unstructured":"Xie B, Zhao L, Guo L, et al. Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt\/\u03b2\u2011catenin pathway. Mol Med Rep. 2019;20(2):1808\u20131818.","journal-title":"Mol Med Rep"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026619666191116160908"},{"issue":"10","key":"e_1_3_5_141_1","first-page":"3","article-title":"Liensinine and nuciferine, bioactive components of nelumbo nucifera, inhibit the growth of breast cancer cells and breast cancer-associated bone loss","volume":"1583185","author":"Kang EJ","year":"2017","unstructured":"Kang EJ, Lee SK, Park KK, et al. Liensinine and nuciferine, bioactive components of nelumbo nucifera, inhibit the growth of breast cancer cells and breast cancer-associated bone loss. Evid Based Complement Alternat Med. 2017;1583185(10):3.","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735413508811"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-017-2775-3"},{"issue":"6","key":"e_1_3_5_144_1","first-page":"3137","article-title":"Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway","volume":"41","author":"Zheng X","year":"2018","unstructured":"Zheng X, Kang W, Liu H, et al. Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway. Int J Mol Med. 2018;41(6):3137\u20133146.","journal-title":"Int J Mol Med"},{"issue":"5763602","key":"e_1_3_5_145_1","article-title":"Recent advances in the pharmacological activities of dioscin","volume":"14","author":"Yang L","year":"2019","unstructured":"Yang L, Ren S, Xu F, et al. Recent advances in the pharmacological activities of dioscin. Biomed Res Int. 2019;14(5763602).","journal-title":"Biomed Res Int"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.01.022"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/pca.2659"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.12.029"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2019.01186"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.02.019"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.01.179"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3290-x"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.377"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.50"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4882"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1130-2"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep45686"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026043387449"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.12.015"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2012.06.007"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.2.292"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.12.2443"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.06.020"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122764"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.06.005"},{"issue":"3","key":"e_1_3_5_166_1","first-page":"648","article-title":"15d-PGJ2 is a new hope for controlling tumor growth","volume":"10","author":"Bie Q","year":"2018","unstructured":"Bie Q, Dong H, Jin C, et al. 15d-PGJ2 is a new hope for controlling tumor growth. Am J Transl Res. 2018;10(3):648\u2013658.","journal-title":"Am J Transl Res"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_235_18"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035569"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S155524"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0838"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040999"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2020.1807950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:40:23Z","timestamp":1732610423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2020.1807950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":169,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1080\/14737140.2020.1807950"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2020.1807950","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}